CCI unrelated to endophthalmitis risk

Article

Clear corneal incision (CCI) is not a risk factor for post-cataract surgery endophthalmitis.

Clear corneal incision (CCI) is not a risk factor for post-cataract surgery endophthalmitis, said I. Howard Fine, MD, at Spotlight on Cataracts 2007.

Speaking in support of the technique he introduced in 1992 and that is now preferred by the overwhelming majority of cataract surgeons, Dr. Fine pointed out that the available literature examining the association between CCI and endophthalmitis is contradictory. While there are some studies demonstrating a relationship, several large studies find the incidence of endophthalmitis is not increased by CCI surgery.

Other factors that need to be considered are changing microbial resistance patterns to antibiotics commonly used for endophthalmitis prophylaxis. Proper CCI construction is also paramount.

"Clearly, not all CCIs are the same and we cannot lump them all together and discuss them as if they were," Dr. Fine said. "The literature on this topic is incomplete because there has been no standardization or description of CCI construction, architecture, or profile in the published studies."

It also appears that more careful attention needs to be paid to construction of the side-port incision, and consideration may be given to the possibility that a shift to temporal surgery accompanying the transition to the CCI may play a role in endophthalmitis rates.

"For a right-handed coaxial surgeon operating on left eyes, the side-port incision is located in the inferior conjunctiva cul-de-sac," Dr. Fine said. "It would be interesting to review the literature reporting an increased incidence of endophthalmitis with CCI to see if it was left eyes that predominated. Perhaps this factor is the culprit in what appears to be an increased incidence of endophthalmitis with the introduction of the CCI."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.